Search for: "Johnson et al v. American Medical Systems, Inc." Results 21 - 29 of 29
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jan 2017, 7:01 am by John Elwood
Amgen Inc., et al., 15-1039 and Amgen Inc. v. [read post]
7 Nov 2008, 3:57 am
Political flurries and potential trade mark wars (Afro-IP) House arrest for DVD pirate (Afro-IP)   Spain Government to publish ‘Manual of Best Practices in the Prosecution of Infringing Activities’ (Class 46)   Ukraine Trade marks database to be accessible free of charge (Class 46)   United Arab Emirates Limitations on trademark protection (International Law Office)   United Kingdom Financing creative businesses (IP finance) UK patent… [read post]
2 May 2008, 7:00 am
: (Intellectual Property Watch), Open licensing vs monopoly controlled supply: (KEI), Protecting inventions involving biofuel feedstock: (IP Law360), Brazil: ‘Public interest’ factor in Brazil’s patenting system: (Spicy IP), EU: Regulation (EC) 1394/2007 on advanced medicinal products to enter into force soon, creating certification procedure regarding quality and non-clinical data: (Catch Us If You Can!!!) [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
4 Apr 2008, 1:00 am
, (Ars Technica), (Patent Prospector), (Washington State Patent Law Blog), (IP Law Observer), (PLI), (PLI), (IP Updates), (Patent Docs), (Peter Zura’s 271 Patent Blog), (The Invent Blog), (IP Spotlight), (Just a Patent Examiner), (Techdirt), (Patent Baristas), (IPBiz), (IPBiz), (Patently-O), (IAM), (IP ThinkTank), (Against Monopoly), (Against Monopoly), (IP Law360), (Hal Wegner), (Ladas & Parry), Global Global - General Virtual monopoly – four strategic choices:… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
29 Feb 2024, 7:15 pm by Barbara Moreno
Silja Voeneky, et. al., eds., The Cambridge Handbook of Responsible Artificial Intelligence:  Interdisciplinary Perspectives (2022). 82. [read post]